Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins

Journal of NeuroVirology

Volumn 13, Issue 2, 2007, Pages 168-172

  Rumbaugh, Jeffrey A ^a   Li, Guanhan ^a   Rothstein, Jeffrey ^a   Nath, Avindra ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beta lactam; Excitotoxicity; Glutamate; Neuroimmunology; Neurotoxicity; Viral

Indexed keywords

CEFTRIAXONE; GLYCOPROTEIN GP 120; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DEMENTIA; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; EMBRYO; FETUS CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL;

CEFTRIAXONE; CELL DEATH; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE PRODUCTS, TAT; HIV ENVELOPE PROTEIN GP120; HUMANS; MITOCHONDRIA; NEURONS; RECOMBINANT PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34249013194     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280601178218     Document Type: Article

References (33)

1. Anderson, C. M. and Swanson, R. A. (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia, 32, pp. 1-14.
2. Bansal, A. K., Mactutus, C. F., Nath, A., Maragos, W., Hauser, K. F. and Booze, R. M. (2000) Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res, 879, pp. 42-49.
3. Billaud, J. N., Selway, D. and Phillips, T. R. (2000) Replication rate of feline immunodeficiency virus in astrocytes is envelope dependent: implications for glutamate uptake. Virology, 266, pp. 180-188.
4. Chen, P., Mayne, M., Power, C. and Nath, A. (1997) The Tat protein of HIV-1 induces tumor necrosis factor-α production: Implications for HIV associated neurological diseases. J Biol Chem, 272, pp. 22385-22388.
5. Corasaniti, M. T., Bellizzi, C., Russo, R., Colica, C., Amantea, D. and Renzo, G Di (2003) Caspase-1 inhibitors abolish deleterious enhancement of COX-2 expression induced by HIV-1 gp120 in human neuroblastoma cells. Toxicol Lett, 139, pp. 213-219.
6. Dore, G. J., McDonald, A., Kaldor, J. M. and Brew, B. J. (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS, 17, pp. 1539-1545.
7. Drejer, J., Meier, E. and Schousboe, A. (1983) Novel neuron-related regulatory mechanisms for astrocytic glutamate and GABA high affinity uptake. Neurosci Lett, 37, pp. 301-306.
8. Haughey, N. J., Nath, A., Mattson, M. P., Slevin, J. T. and Geiger, J. D. (2001) HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem, 78, pp. 457-467.
9. Lafortune, L., Nalbantoglu, J. and Antel, J. P. (1996) Expression of tumor necrosis factor alpha (TNF alpha) and interleukin 6 (IL-6) mRNA in adult human astrocytes: Comparison with adult microglia and fetal astrocytes. J Neuropathol Exp Neurol, 55, pp. 515-521.
10. Lipton, S. A. (1994) AIDS related dementia and calcium homeostasis. Ann N Y Acad Sci, 594, pp. 189-196.
11. Nath, A. (1997) Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol, 71, pp. 2495-2499.
12. Magnuson, D. S., Knudsen, B. E., Geiger, J. D., Brownstone, R. M. and Nath, A. (1995) Human immunodeficiency virus type 1 tat activates non-N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol, 37, pp. 373-380.
13. McArthur, J. C., Haughey, N., Gartner, S., Conant, K., Pardo, C., Nath, A. and Sacktor, N. (2003) Human immunodeficiency virus-associated dementia: An evolving disease. J NeuroVirol, 9, pp. 205-221.
14. Nath, A., Haughey, N. J., Jones, M., Anderson, C., Bell, J. E. and Geiger, J. D. (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine. Ann Neurol, 47, pp. 186-194.
15. Nath, A., Psooy, K., Martin, C., Knudsen, B., Magnuson, D. S., Haughey, N. and Geiger, J. D. (1996) Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol, 70, pp. 1475-1480.
16. Neuenburg, J. K., Brodt, H. R., Herndier, B. G., Bickel, M., Bacchetti, P., Price, R. W., Grant, R. M. and Schlote, W. (2002) HIV-related neuropathology, 1985 to 1999: Rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr, 31, pp. 171-177.
17. Olsen, C., Rustad, A., Fonnum, F., Paulsen, R. E. and Hassel, B. (1999) 3-Nitropropionic acid: An astrocyte-sparing neurotoxin in vitro. Brain Res, 850, pp. 144-149.
18. Prendergast, M. A., Rogers, D. T., Mulholland, P. J., Littleton, J. M., Wilkins Jr., L. H., Self, R. L. and Nath, A. (2002) Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor. Brain Res, 954, pp. 300-307.
19. Ranki, A., Nyberg, M., Ovod, V., Haltia, M., Elovaara, I., Raininko, R., Haapasalo, H. and Krohn, K. (1995) Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS, 9, pp. 1001-1008.
20. Robinson, M. B. (1998) The family of sodium-dependent glutamate transporters: A focus on the GLT-1/EAAT2 subtype. Neurochem Int, 33, pp. 479-491.
21. Rosen, C. A., Terwilliger, E., Dayton, A., Sodroski, J. G. and Haseltine, W. A. (1988) Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc Natl Acad Sci USA, 85, pp. 2071-2075.
22. Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Hoberg, M Dykes, Vidensky, S., Chung, D. S., Toan, S. V., Bruijn, L. I., Su, Z. Z., Gupta, P. and Fisher, P. B. (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature, 433, pp. 73-77.
23. Sacktor, N. (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J NeuroVirol, 8, pp. 115-121.
24. Sacktor, N., McDermott, M. P., Marder, K., Schifitto, G., Selnes, O. A., McArthur, J. C., Stern, Y., Albert, S., Palumbo, D., Kieburtz, K., De Marcaida, J. A., Cohen, B. and Epstein, L. (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol, 8, pp. 136-142.
25. Saito, Y., Sharer, L. R., Epstein, L. G., Michaels, J., Mintz, M., Louder, M., Golding, K., Cvetkovich, T. A. and Blumberg, B. M. (1994) Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology, 44, pp. 474-481.
26. Scheld, W. M., Rocha, H., Sande, M. A. and Bryan, J. P. (1984) Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis. Am J Med, 77, pp. 42-49.
27. Szymocha, R., Akaoka, H., Dutuit, M., Malcus, C., Didier-Bazes, M., Belin, M. F. and Giraudon, P. (2000) Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha. J Virol, 74, pp. 6433-6441.
28. Tornatore, C., Chandra, R., Berger, J. R. and Major, E. O. (1994) HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology, 44, pp. 481-487.
29. Turchan, J., Anderson, C., Hauser, K. F., Sun, Q., Zhang, J., Liu, Y., Wise, P. M., Kruman, I., Maragos, W., Mattson, M. P., Booze, R. and Nath, A. (2001) Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci, 2, p. 3.
30. Wahl, L. M., Corcoran, M. L., Pyle, S. W., Arthur, L. O., Harel-Bellan, A. and Farrar, W. L. (1989) Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci USA, 86, pp. 621-625.
31. Wang, Z., Pekarskaya, O., Bencheikh, M., Chao, W., Gelbard, H. A., Ghorpade, A., Rothstein, J. D. and Volsky, D. J. (2003) Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology, 312, pp. 60-73.
32. Wang, Z., Trillo-Pazos, G., Kim, S. Y., Canki, M., Morgello, S., Sharer, L. R., Gelbard, H. A., Su, Z. Z., Kang, D. C., Brooks, A. I., Fisher, P. B. and Volsky, D. J. (2004) Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: Potential role in neuropathogenesis. J NeuroVirol, 10, pp. 25-32.
33. Yu N, Billaud, J. N. and Phillips, T. R. (1998) Effects of feline immunodeficiency virus on astrocyte glutamate uptake: Implications for lentivirus-induced central nervous system diseases. Proc Natl Acad Sci USA, 95, pp. 2624-2629.